- Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome2008 | Second Faculty of Medicine
- Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL2023 | Second Faculty of Medicine, Central Library of Charles University
- Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells2010 | Central Library of Charles University
- Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies2008 | Second Faculty of Medicine
- JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility2019 | Second Faculty of Medicine
- Polycythemia vera is not initiated by JAK2(V617F) mutation2007 | First Faculty of Medicine
- Polycythemia vera is not initiated by JAK2(V617F) mutation2007 | Faculty of Physical Education and Sport
- Coexistence of gain-of-function JAK2 germ line mutations with JAK2(V617F) in polycythemia vera2016 | First Faculty of Medicine
- Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of Register for the 1st quarter of 20102010 | Faculty of Medicine in Hradec Králové
- Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera2016 | Faculty of Science
- JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome- negative CML, and megakaryocytic leukemia2005 | First Faculty of Medicine
- JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome- negative CML, and megakaryocytic leukemia2005 | Faculty of Physical Education and Sport
- In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele2007 | First Faculty of Medicine
- In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele2007 | Faculty of Physical Education and Sport
- JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia2007 | Second Faculty of Medicine
- High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension2006 | First Faculty of Medicine
- High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension2006 | Faculty of Physical Education and Sport
- Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome2009 | Second Faculty of Medicine
- Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- Ph(-)myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Rat Chromosome 1: regional localization of seven genes (Slc9a3, Srd5a1, Esr, Tcp1, Grik5, Tnnt3, Jak2) and anchoring of the genetic linkage map to the cytogenetic map.1997 | Faculty of Physical Education and Sport
- What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocytopenia, and what can be the predictive sign of the risk of thrombosis in such patients - a report from the registry of patients treated by Thromboreductine +12008 | Faculty of Medicine in Hradec Králové
- The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group2008 | Second Faculty of Medicine
- What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocytopenia and what can be the predictive sign of the risk of thrombosis in such patients - a report from the registry of patie2008 | First Faculty of Medicine
- Aberrant expression of microRNA in polycythemia vera2008 | First Faculty of Medicine
- Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases - principles and rationale of CZEMP recommendations2011 | Second Faculty of Medicine
- Janus kinase inhibitors in the treatment of rheumatoid arthritis2020 | First Faculty of Medicine
- Postavení inhibitorů Janusových kináz v revmatologii2023 | First Faculty of Medicine
- Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis2007 | First Faculty of Medicine